Haemonetics Anticoagulant Sodium Citrate (Haemonetics Corporation)
Welcome to the PulseAid listing for the Haemonetics Anticoagulant Sodium Citrate drug offered from Haemonetics Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Corporation |
| NON-PROPRIETARY NAME: | TRISODIUM CITRATE DIHYDRATE |
| SUBSTANCE NAME: | TRISODIUM CITRATE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | EXTRACORPOREAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-01-10 |
| END MARKETING DATE: | 0000-00-00 |
Haemonetics Anticoagulant Sodium Citrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Haemonetics Anticoagulant Sodium Citrate from Haemonetics Corporation |
| LABELER NAME: | Haemonetics Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/mL) |
| START MARKETING DATE: | 2013-01-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57826-420_5c644a2c-2dc3-c305-e053-2991aa0a97fe |
| PRODUCT NDC: | 57826-420 |
| APPLICATION NUMBER: | BN980123 |
Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
